BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 2677968)

  • 1. [Autoimmunity and insulin-dependent diabetes mellitus. Experimental data and therapeutic prospects].
    Thivolet C; Khallouf E
    Pediatrie; 1989; 44(4):247-57. PubMed ID: 2677968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune disorders in diabetes.
    Boitard C; Debray-Sachs M; Bach JF
    Adv Nephrol Necker Hosp; 1986; 15():281-305. PubMed ID: 3082114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients.
    Itoh N; Hanafusa T; Miyazaki A; Miyagawa J; Yamagata K; Yamamoto K; Waguri M; Imagawa A; Tamura S; Inada M
    J Clin Invest; 1993 Nov; 92(5):2313-22. PubMed ID: 8227346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological disorders of type 1 diabetes mellitus.
    Ziegler M; Ziegler B
    Exp Clin Endocrinol; 1989 Sep; 94(1-2):97-114. PubMed ID: 2689194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Latent autoimmune diabetes in adults(LADA): part of the clinical spectrum of type-1 diabetes mellitus of autoimmune origin].
    Pánczél P; Hosszúfalusi N; Bornemisza B; Horváth L; Jánoskuti L; Füst G; Rajczy K; Vatay A; Prohászka Z; Madácsy L; Luczay A; Blatniczky L; Halmos T; Körner A; Szilvási I; Romics L
    Orv Hetil; 2001 Nov; 142(46):2571-8. PubMed ID: 11770176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An explanation for the protective effect of the MHC class II I-E molecule in murine diabetes.
    Reich EP; Sherwin RS; Kanagawa O; Janeway CA
    Nature; 1989 Sep; 341(6240):326-8. PubMed ID: 2507922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of glucose transporter-2 precedes insulin loss in the nonobese diabetic and the low-dose streptozotocin mouse models: a comparative immunohistochemical study by light and confocal microscopy.
    Reddy S; Young M; Poole CA; Ross JM
    Gen Comp Endocrinol; 1998 Jul; 111(1):9-19. PubMed ID: 9653017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and immunological basis of autoimmune diabetes in the NOD mouse.
    Yoshida K; Kikutani H
    Rev Immunogenet; 2000; 2(1):140-6. PubMed ID: 11324686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathological changes in the islet milieu precede infiltration of islets and destruction of beta-cells by autoreactive lymphocytes in a transgenic model of virus-induced IDDM.
    von Herrath M; Holz A
    J Autoimmun; 1997 Jun; 10(3):231-8. PubMed ID: 9218748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
    Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A
    J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
    Gallichan WS; Balasa B; Davies JD; Sarvetnick N
    J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of genetic and immunological factors in the etiology of insulin-dependent diabetes].
    Deschamps I; Hors J; Robert JJ
    Schweiz Med Wochenschr; 1990 Jan; 120(3):46-53. PubMed ID: 2405478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-tolerance and differential susceptibility to diabetes in transgenic mice expressing major histocompatibility class II genes on pancreatic beta cells.
    Götz J; Eibel H; Köhler G
    Eur J Immunol; 1990 Aug; 20(8):1677-83. PubMed ID: 2209682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of insulin-dependent diabetes mellitus (IDDM) in NOD mice by autoreactive T cells.
    Chaturvedi P; Qin HY; Chou H; Singh B
    Crit Rev Immunol; 1997; 17(5-6):519-28. PubMed ID: 9419439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in adhesion markers, activation markers, and TcR in islet infiltrating vs. peripheral lymphocytes in the NOD mouse.
    Goldrath AW; Barber L; Chen KE; Alters SE
    J Autoimmun; 1995 Apr; 8(2):209-20. PubMed ID: 7612149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune mechanisms in type 1 diabetes.
    Knip M; Siljander H
    Autoimmun Rev; 2008 Jul; 7(7):550-7. PubMed ID: 18625444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmunity to islet cells in diabetes mellitus.
    Powers AC; Eisenbarth GS
    Annu Rev Med; 1985; 36():533-44. PubMed ID: 3888064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of autoimmune insulitis by expression of I-E molecules in NOD mice.
    Nishimoto H; Kikutani H; Yamamura K; Kishimoto T
    Nature; 1987 Jul 30-Aug 5; 328(6129):432-4. PubMed ID: 3302721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspartate at position 57 of nonobese diabetic I-Ag7 beta-chain diminishes the spontaneous incidence of insulin-dependent diabetes mellitus.
    Quartey-Papafio R; Lund T; Chandler P; Picard J; Ozegbe P; Day S; Hutchings PR; O'Reilly L; Kioussis D; Simpson E
    J Immunol; 1995 May; 154(10):5567-75. PubMed ID: 7730655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Type 1 diabetes mellitus, autoimmune disease: physiopathologic aspects and practical applications].
    Timsit J; Boitard C; Bach JF
    Ann Biol Clin (Paris); 1991; 49(3):149-53. PubMed ID: 2064084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.